ID   LA-49
AC   CVCL_M531
SY   LA 49
DR   Wikidata; Q54901871
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=4858717;
RX   PubMed=10936422;
CC   Characteristics: Produces IgD lambda.
CC   Miscellaneous: Cell line has been lost (PubMed=10936422).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 15
//
RX   PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2;
RA   Drexler, Hans Gunther
RA   Matsuo, Yoshinobu
RT   "Malignant hematopoietic cell lines: in vitro models for the study of
RT   multiple myeloma and plasma cell leukemia.";
RL   Leuk. Res. 24:681-703(2000).
//
RX   PubMed=4858717; DOI=10.1084/jem.140.2.494; PMCID=PMC2139596;
RA   Jobin, M.E.
RA   Fahey, John Leslie
RA   Price, Zane H.
RT   "Long-term establishment of a human plasmacyte cell line derived from
RT   a patient with IgD multiple myeloma. I. Requirement of a
RT   plasmacyte-stimulating factor for the proliferation of myeloma cells in
RT   tissue culture.";
RL   J. Exp. Med. 140:494-507(1974).
//
RX   DOI=10.1007/0-306-46877-8_4;
RA   Jernberg-Wiklund, Helena
RA   Nilsson, Kenneth
RT   "Multiple myeloma cell lines.";
RL   (In book chapter) Human cell culture. Vol. 3. Cancer cell lines part 3; Masters, John R.W. & Palsson, Bernhard Orn (eds.); pp.81-155; Kluwer Academic Publishers; New York; USA (2000).
//